Controversies in current immunization policy and practices: One physician's viewpoint

Abrutyn, 1970, Rubella vaccine comparative study. Nine-month follow-up and serologic response to natural challenge, Am. J. Dis. Child., 120, 129, 10.1001/archpedi.1970.02100070073007 Aftandelians, 1973, Bactericidal antibody in serum during infection with Bordetella pertussis, J. Infect. Dis., 128, 555, 10.1093/infdis/128.4.555 1966, American Public Health Association Committees and Association Representatives 1965–1966, Am. J. Public Health, 56, 331 Bloom, 1975, Evaluation of a trivalent measles, mumps, rubella vaccine in children, J. Pediat., 87, 85, 10.1016/S0022-3476(75)80076-X Bordet, 1906, Le microbe de coque-luche, Ann. Inst. Pasteur, 20, 731 Boue, 1971, Reinfection with rubella in pregnant women, Lancet, 1, 1251, 10.1016/S0140-6736(71)91775-2 Bunyak, 1969, Combined live measles, mumps, and rubella virus vaccine, JAMA, 207, 2259, 10.1001/jama.1969.03150250089009 Center for Disease Control, 1974 Center for Disease Control, 1971, Rubella Surveillance, Report no. 3 (Atlanta, Georgia) Center for Disease Control, 1972, Rubella Surveillance, Report no. 3 (Atlanta, Georgia) Center for Disease Control: U.S. Immunization Survey-1973 (Atlanta: CDC and the Bureau of the Census). 1973, Certain viral vaccines containing unavoidable bacteriophage, Federal Register, 38, 11080 Chang, 1970, Clinical and serologic studies of an outbreak of rubella in a vaccinated population, N. Engl. J. Med., 283, 246, 10.1056/NEJM197007302830507 Cooper, 1967, Clinical manifestations of postnatal and congenital rubella, Arch. Ophthalmol., 77, 434, 10.1001/archopht.1967.00980020436004 Council, 1966, Measles immunization, JAMA, 198, 837, 10.1001/jama.1966.03110210087026 Cravitz, 1945, Pertussis immunization program of the Boston Health Department, JAMA, 129, 539, 10.1001/jama.1945.02860420007003 Davis, 1971, A study of rubella immunity and resistance to infection, JAMA, 215, 600, 10.1001/jama.1971.03180170036007 Dufour, 1946, Correlation between the potency of mumps skin test antigen and cutaneous delayed hypersensitivity and resistance to mumps, J. Exp. Med., 84, 341, 10.1084/jem.84.4.341 Edwards, 1971, Rubella infections in navy recruits, Bacteriol. Proc., 51, 176 Enders, 1946, Immunity in mumps. V. The correlation of the presence of dermal hypersensitivity and resistance to mumps, J. Exp. Med., 84, 341, 10.1084/jem.84.4.341 Fleet, 1975, Gestational exposure to rubella vaccinees, Am. J. Epidemiol., 101, 220, 10.1093/oxfordjournals.aje.a112089 Foege, 1971, Current status of global smallpox eradication, Am. J. Epidemiol., 93, 223, 10.1093/oxfordjournals.aje.a121250 Fraumeni, 1963, Evaluation of carcinogenicity of simian virus 40 in man, JAMA, 185, 713, 10.1001/jama.1963.03060090045016 Fulginiti, 1968, Altered reactivity to measles virus, Am. J. Dis. Child., 115, 671, 10.1001/archpedi.1968.02100010673006 Fulginiti, 1969, Respiratory virus immunization. 1. A field trial of two inactivated respirtory virus vaccines; an aqueous, trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine, Am. J. Epidemiol., 89, 435, 10.1093/oxfordjournals.aje.a120956 Gard, 1967, Inactivated Poliomyelitis Vaccine: Present and Future, 161 Gasser, 1974, Genetic determinants of immunological responsiveness, Adv. Immunol., 18, 1, 10.1016/S0065-2776(08)60307-7 Gostling, 1974, Whooping cough vaccination, Lancet, 2, 773, 10.1016/S0140-6736(74)90959-3 Gostling, 1975, Whooping cough vaccination, Lancet, 1, 569, 10.1016/S0140-6736(75)91576-7 Hardy, 1970, Trivalent oral poliovirus vaccine: A comparison of two infant immunization schedules, Pediatrics, 45, 444 Harris, 1968, Mumps in a northeast metropolitan community, Am. J. Epidemiol., 88, 224, 10.1093/oxfordjournals.aje.a120881 Hattis, 1973, Rubella in an immunized island population, JAMA, 223, 1019, 10.1001/jama.1973.03220090039008 Hilleman, 1968, Cells, vaccines and the pursuit of precedent, Progr. Med. Virol., 10, 348 Hilleman, 1968, Live, attenuated mumps-virus vaccine, N. Engl. J. Med., 278, 227, 10.1056/NEJM196802012780501 Holt, 1972, The pathology and immunology of Bordetella pertussis infection, J. Med. Microbiol., 5, 407, 10.1099/00222615-5-4-407 Isacson, 1971, Allergic reactions associated with viral vaccines, Progr. Med. Virol., 13, 239 Islur, 1975, The whooping cough syndrome: A continuing pediatric problem, Clin. Pediatr., 14, 171, 10.1177/000992287501400208 Jenner, 1896 Karchmer, 1970, Letter to the Editor: Seroconversion in rubella-vaccine trials, N. Engl. J. Med., 283, 820, 10.1056/NEJM197010082831519 Karchmer, 1969, Comparative studies of rubella vaccines, Am. J. Dis. Child., 118, 197 Katz, 1964, Efficacy, potential and hazards of vaccines, N. Engl. J. Med., 270, 884, 10.1056/NEJM196404232701707 Katz, 1974, Letter to the Editor, Newsletter, Am. Acad. Peds. Kempe, 1960, Studies on smallpox and complications of smallpox vaccination, Pediatiics, 26, 176 Kendrick, 1947, Mouse protection test in the study of pertusis vaccine, Am. J. Public Health, 37, 803, 10.2105/AJPH.37.7.803-b Kendrick, 1969, Pertussis agglutinins in adults, Public Health Rep., 84, 9, 10.2307/4593487 Klock, 1973, Failure of herd immunity during an epidemic, N. Engl. J. Med., 288, 69, 10.1056/NEJM197301112880204 Lambert, 1965, Epidemiology of a small pertussis outbreak in Kent County, Michigan, Public Health Rep., 80, 365, 10.2307/4592424 Lane, 1969, Complications of smallpox vaccination, 1968. National surveillance in the United States, N. Engl. J. Med., 281, 1201, 10.1056/NEJM196911272812201 Lefkowitz, 1970, A controlled family study of live, attenuated rubella-virus vaccine, N. Engl. J. Med., 283, 229, 10.1056/NEJM197007302830504 Lehane, 1970, Evaluation of rubella herd immunity during an epidemic, JAMA, 213, 2236, 10.1001/jama.1970.03170390028004 Linnemann, 1974, Pertussis: Persistent problems, J. Pediatr., 85, 589, 10.1016/S0022-3476(74)80496-8 Madsen, 1933, Vaccination against whooping cough, JAMA, 101, 187, 10.1001/jama.1933.02740280007003 Malmgren, 1960, Complications of immunization, Br. Med. J., 2, 1800, 10.1136/bmj.2.5215.1800 Maris, 1946, Immunity in mumps. IV. The correlation of CF antibody and resistance to mumps in human beings, J. Exp. Med., 84, 323, 10.1084/jem.84.4.323 Mayr, 1971, Foreign virus contamination of human smallpox vaccines (dermovaccinia from cattle and sheep), Zentral Veterinaermed (B), 18, 679, 10.1111/j.1439-0450.1971.tb01673.x Medical Research Council Investigation, 1956, Br. Med. J., 2, 454, 10.1136/bmj.2.4990.454 Medical Research Council Investigation, 1959, Br. Med. J., 1, 994, 10.1136/bmj.1.5128.994 Medical Research Council Investigation, 1951, The prevention of whooping cough by vaccination, Br. Med. J., 1, 1463, 10.1136/bmj.1.4721.1463 Meyer, 1971, Rubella vaccination—A review of practical experience, JAMA, 215, 613, 10.1001/jama.1971.03180170049009 Meyer, 1966, Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial, N. Engl. J. Med., 275, 575, 10.1056/NEJM196609152751102 Miller, 1954, Neurologic sequelae of prophylactic inoculation, Quart. J. Med., 89, 1 1948 Mishulow, 1942, A study of pertussis antibodies: Protective agglutinins and complement-fixing antibodies in patients with pertussis, persons exposed to pertussis, and persons with no known exposure, Am. J. Dis. Child., 63, 875, 10.1001/archpedi.1942.02010050039004 Modlin, 1975, A review of five year's experience with rubella vaccine in the United States, Pediatrics, 55, 1 Moody, 1975, Bacteriophages and endotoxin in licensed live-virus vaccines, J. Infect. Dis., 131, 588, 10.1093/infdis/131.5.588 1975, 24, 243 1967, 16, 51 1969, 18, 124 1971, 20, 339 1973, 22, 110 Morse, 1968, Pertussis in adults, Ann. Intern. Med., 68, 953, 10.7326/0003-4819-68-4-953 Murray, 1971, V-B, Problems in the Licensing of New Vaccines Northrup, 1972, Rubella reinfection during early pregnancy, Obstet. Gynecol., 39, 524 Paschlau, 1965, Erfahrungen mit aktiven Schutzimpfungen gegen Keuchhusten, Oeff. Gesundheitswes., 27, 123 Pasteur, 1885, Methode pour prevenir la rage apres morsure, Compt. Rend. Acad. Sci., 101, 765 Paton, 1937, The diagnosis of whooping cough, the complement-fixation and intradermal skin tests, Lancet, 1, 132, 10.1016/S0140-6736(00)97656-6 Perkins, 1974, Vaccination against whooping-cough, Lancet, 2, 773 Pollard, 1975, Epidemiologic survey of rubella in a military recruit population, Am. J. Epidemiol., 101, 431, 10.1093/oxfordjournals.aje.a112110 Preston, 1975, Whooping cough vaccination, Lancet, 1, 569 1969, 118, 1 1969, Public Health Laboratory Service Whooping Cough Committee and Working Party Report, Br. Med. J., 4, 429 1974 Reyes vs. Wyeth, #72-2251, U.S. Court of Appeals, 5th Circuit. Ruiz-Gomez, 1971, Evaluatcion de la vacuna contra la rubeola (posible transmision de la cepa vacunal), Arch. Invest. Med. (Mexico), 2, 95 Saidi, 1969, Subcutaneous and intranasal administration of RA 27/3 rubella vaccine, Am. J. Dis. Child., 18, 209, 10.1001/archpedi.1969.02100040211009 Sako, 1947, Studies on pertussis immunization, J. Pediatr., 30, 29, 10.1016/S0022-3476(47)80280-X Salk, 1959, Vaccination against poliomyelitis—an ounce of prevention, Royal Soc. Health J., 79, 310, 10.1177/146642405907900405 Salk, 1961, Viral diseases; their control by immunologic means, Postgrad. Med., 30, 99, 10.1080/00325481.1961.11694349 Schiff, 1970, Probable transmission of rubella vaccine virus strain, Clin. Res., 18, 446 Strannegard, 1970, Case of apparent reinfection with rubella, Lancet, 1, 240, 10.1016/S0140-6736(70)90595-7 Strom, 1967, Further experience of reactions, especially of a cerebral nature in conjunction with triple vaccination. A study based on vaccinations in Sweden 1959–65, Br. Med. J., 4, 320, 10.1136/bmj.4.5575.320 Strom, 1960, Is universal vaccination against pertussis always justified?, Br. Med. J., 2, 1184, 10.1136/bmj.2.5207.1184 Sweet, 1960, Detection of a Non-detectable Simian Virus (Vacuolating Agent) Present in Rhesus and Cynomalogous Monkey-Kidney Cell Culture Material, 79 U.S. Department of Health, Education, and Welfare, 1962 1974, Vaccination against whooping cough, Br. Med. J., 2, 539 Wallace, 1972, Comparative trial of HPV-77 DE-5 and RA-27/3 live attenuated rubella vaccines, Am. J. Dis. Child., 124, 536 Weibel, 1975, Long-term follow-up after monovalent or combined live measles, mumps and rubella virus vaccines, Pediatrics, 56, 380, 10.1542/peds.56.3.380 Weibel, 1972, Measurement of immunity following live mumps (5 years), measles (3 years), and rubella (2 1/2 years) virus vaccines, Pediatrics, 49, 334, 10.1542/peds.49.3.334 Weibel, 1970, Persistence of immunity four years following Jeryl Lynn strains live mumps virus vaccine, Pediatrics, 45, 821, 10.1542/peds.45.5.821 Wilkins, 1971, Transmission of rubella vaccine virus from vaccinees to contacts, Calif. Med., 115, 16 Wilkins, 1971, Agglutinin response to pertussis vaccine, J. Pediatr., 79, 197, 10.1016/S0022-3476(71)80101-4 Wilson, 1967, 195 Wilson, 1967, 253 Wilson, 1962, Measles as a universal disease, Am. J. Dis. Child., 103, 219 Winter, 1953, Development of antibodies in children convalescent from whooping cough, Proc. Soc. Exp. Biol. Med., 83, 866, 10.3181/00379727-83-20517 Winter, 1956, Studies in pertussis immunity, Proc. Soc. Exp. Biol. Med., 92, 832, 10.3181/00379727-92-22628 Witte, 1969, Epidemiology of rubella, Am. J. Dis. Child., 118, 107 Witte, 1968, Surveillance of mumps in the U.S. as background for the use of vaccine, Public Health Rep., 83, 95, 10.2307/4593236